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        Introduction 
 Amyloid-    (A   ) is thought to be the principle cause of the 
pathogenesis and progression of the neuron and memory loss 
associated with Alzheimer  ’  s disease (AD; for review see   Barnham 
et al., 2006  ). Substantial evidence suggests that A   -induced 
neuronal apoptosis is central to the progression of AD (  Abad 
et al., 2006  ;   Biswas et al., 2007  ). This has prompted investiga-
tion of the potential for caspase family cystein proteases, which 
are activated during apoptosis and execute various apoptotic 
processes to serve as therapeutic targets in the treatment of neuro-
degenerative diseases (  Sanges et al., 2006  ;   Emamaullee et al., 
2007  ). Among the 14 caspase isoforms known to be expressed 
in mammals, the ER-resident caspase-12 was initially identifi  ed 
as a mediator of A     neurotoxicity, and its conserved pathway, 
termed   “  ER stress,  ”   has been implicated in the pathogenesis of 
such neurodegenerative ailments as Huntington  ’  s disease, prion 
disease, and AD (  Nakagawa et al., 2000  ;   Kouroku et al., 2002  ; 
  Hetz et al., 2003, 2007  ;   Hoozemans et al., 2007  ). However, the 
functional role of caspase-12 in humans remains to be further 
clarifi  ed. Human caspase-12 has no role in apoptotic pathways 
(  Saleh et al., 2004  ) and it is still controversial that human cas-
pase-12 acts as a functional counterpart of mouse caspase-12. 
Interestingly, the amino acid sequence of mouse caspase-12 has 
a 61% identity with human caspase-4, which is involved in 
apoptosis induced by ER stress (  Hitomi et al., 2004  ) in the 
 interleukin-1 – converting  enzyme  homologous  region.  Thus,  a 
fuller understanding of the mechanisms involved in regulating 
ER stress, caspase-12 activity, and their roles in A     neurotoxicity 
would be highly desirable. 
  The ubiquitin/proteasome system (UPS) is involved in 
many biological pathways, including regulation of the cell cycle 
and modulation of the degradation of short-lived and regulatory 
proteins (for review see   Rubinsztein, 2006  ). Protein degrada-
tion by the UPS proceeds through two successive steps: (1) 
ubiquitination, i.e., conjugation of ubiquitin to a target protein 
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tribute to the pathogenesis of Alzheimer  ’ s disease 
(AD). Previously we found that E2-25K/Hip-2, 
an E2 ubiquitin-conjugating enzyme, mediates A     neuro-
toxicity. Here, we report that E2-25K/Hip-2 modulates 
caspase-12 activity via the ubiquitin/proteasome system. 
Levels of endoplasmic reticulum (ER)  –  resident caspase-12 
are strongly up-regulated in the brains of AD model mice, 
where the enzyme colocalizes with E2-25K/Hip-2. A     in  -
creases expression of E2-25K/Hip-2, which then stabilizes 
caspase-12 protein by inhibiting proteasome activity. This in-
crease in E2-25K/Hip-2 also induces proteolytic activation 
of caspase-12 through its ability to induce calpainlike 
activity. Knockdown of E2-25K/Hip-2 expression suppresses 
neuronal cell death triggered by ER stress, and thus 
caspase-12 is required for the E2-25K/Hip-2  –  mediated 
cell death. Finally, we ﬁ  nd that E2-25K/Hip-2  –  deﬁ  cient 
cortical neurons are resistant to A     toxicity and to the in-
duction of ER stress and caspase-12 expression by A    . 
E2-25K/Hip-2 is thus an essential upstream regulator of 
the expression and activation of caspase-12 in ER stress  –
  mediated A     neurotoxicity.
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Tg2576 mouse brain than in their wild-type littermates (  Fig. 1 A  ). 
Interestingly, the E2-25K/Hip-2 immunoreactivity colocalized 
with that of caspase-12 around amyloid plaques, but not with 
that of caspase-2, which is also known to mediate A     neuro-
toxicity ( Troy et al., 2000 ). In addition, Western blotting showed 
that levels of both caspase-12 and E2-25K/Hip-2 were increased 
in the brains of 6- and 9-mo-old double transgenic mice ex-
pressing Swedish mutant A     precursor protein (APPswe) and 
exon 9  –  deleted presenilin 1 (PS1dE9;   Fig. 1, B and C  ). These 
results imply there is concerted regulation of caspase-12 and 
E2-25K/Hip-2 in the brains of these AD model mice. 
  We then examined the expression and activation of cas-
pase-12 in rat B103 neuroblastoma cells stably expressing the 
antisense E2-25K/Hip-2 cDNA (B103/E2-25K-AS cells;   Fig. 2 A  , 
left). As compared with control cells, mixed populations of 
B103/E2-25K-AS cells showed reduced expression of caspase-12 
but no changes in the expression of caspase-2 and -8 ( Fig. 2 A , 
right). Treatment with A     induced the accumulation and pro-
teolytic processing of caspase-12 in control cells, but these 
effects were substantially reduced in B103/E2-25K-AS cells. 
Conversely, ectopic expression of E2-25K/Hip-2 effi  ciently in-
duced proteolytic activation of caspase-12 in B103 cells (  Fig. 2 B  ). 
Collectively, these results suggest that A   -induced  accumu-
lation and the proteolytic activation of caspase-12 protein may 
be mediated by E2-25K/Hip-2. RT-PCR analysis showed that 
the basal levels of caspase-12 mRNA in B103/E2-25K-AS cells 
were also somewhat lower than in control cells (  Fig. 2 C  , left) 
and that caspase-12 mRNA was apparently induced by A     in 
control cells but not in B103/E2-25K-AS #1 cells (  Fig. 2 C  , 
right). When reporter assays were performed with pGL3-3.0 
(5    fl anking region + 1 ’  intron + 2 ’  exon) and pGL3-0.8 (1 ’  intron + 
2  ’   exon;   Oubrahim et al., 2005  ), the promoter activity of 
caspase-12 was weak in B103 cells (twofold higher than control) 
compared with NIH 3T3 cells (sevenfold higher than control; 
via the sequential actions of ubiquitin-activating (E1), ubiquitin-
conjugating (E2), and ubiquitin-ligating (E3) enzymes; and 
(2) degradation, i.e., recognition of the Lys48 polyubiquitin 
chain by 26S proteasome and degradation of the target protein 
with generation of free ubiquitin by ubiquitin-recycling enzymes. 
Malfunction of the UPS leading to accumulation of aggrega-
tion-prone proteins is thought to be involved in some neuro-
degenerative diseases including AD (  Al-Ramahi et al. 2006  ; 
  Kristiansen et al., 2007  ; for review see   Rubinsztein, 2006  ). Indeed, 
it was proposed that E2-25K/Hip-2, an E2 ubiquitin-conjugating 
enzyme, acts as an essential mediator of A     neurotoxicity  by 
promoting the inhibition of proteasome (  Song et al., 2003  ; for 
review see   Song and Jung, 2004  ). Furthermore, other evidence 
has shown that the inhibition of proteasome activity promotes 
ER stress (  Nishitoh et al., 2002  ), suggesting that altered regula-
tion of proteasome activity and ER stress may be associated 
with A     neurotoxicity. However, a critical mediator coordi-
nating ER stress and caspase-12 activity in A     neurotoxicity 
remains unknown. Here we show that E2-25K/Hip-2 regulates 
the activation of caspase-12 and ER stress responses during A    
neurotoxicity, and that E2-25K/Hip-2  –  defi  cient cortical neurons 
cultured from E2-25K/Hip-2 knockout mice lack A   -induced 
ER stress responses, including accumulation of caspase-12, and 
are resistant to A     toxicity. 
  Results 
  Regulation of caspase-12 expression 
by E2-25K/Hip-2 during A     toxicity 
  To assess the relationship between E2-25K/Hip-2 and caspase-12, 
we initially performed an immunohistochemical analysis of the 
brains of Tg2576 mice (  Hsiao et al., 1996  ). We found that, as 
with E2-25K/Hip-2 (  Song et al., 2003  ), there was much greater 
expression of caspase-12 in the hippocampal region of the 
  Figure 1.       Colocalization and increased expression of caspase-12 and E2-25K/Hip-2 in the brains of Tg2576 and APPswe/PS1dE9 mice.   (A) Hippocam-
pal region of 21-mo-old Tg2576 mice and age-matched littermates were immunostained using anti  –  E2-25K/Hip-2, anticaspase-12 (middle and bottom), 
and anticaspase-2 (top) antibodies and examined under a ﬂ  uorescence microscope. Asterisks indicate amyloid plaques. (B) Whole brains from APPswe/
PS1dE9 (APP/PS) mice and wild-type (WT) littermates were harvested at the indicated ages and examined by Western blotting with anti  –  E2-25K/Hip-2, 
anticaspase-12, and anti  –      -tubulin antibodies. (C) Caspase-12 and E2-25K/Hip-2 signals at 9 mo in B were quantiﬁ  ed by densitometry using the histogram 
feature in Photoshop. Bars depict means   ±   SD (  n   = 3). P-values were calculated using   t   tests and are versus control.     677 REGULATION OF CASPASE-12 BY E2-25K   •   S  ong et al. 
tion of caspase-12, but not the expression of at least some ER 
stress markers. 
  Given our fi  nding that the expression and activation of 
caspase-12 is regulated by E2-25K/Hip-2, we were eager to 
know whether caspase-12 is a downstream mediator of E2-25K/
Hip-2 in the cell death (  Fig. 3 ).  As  compared  with the rela-
tively weak proapoptotic activities of E2-25K/Hip-2 (32%) 
and caspase-12 (26%) alone, coexpressed E2-25K/Hip-2 and 
caspase-12 acted synergistically to efficiently induce apop-
tosis (76%) in B103 cells (  Fig. 3 A  ). In addition, ectopic ex-
pression of a caspase-12 active site mutant (Cys298  → Ser) 
signifi  cantly suppressed apoptosis triggered by E2-25K/Hip-2. 
Also, caspase-12 knockout mouse embryonic fi  broblasts (MEFs; 
C12 [   /   ]) were resistant to cell death induced by the over-
expression of E2-25K/Hip-2 but not to cell death induced by 
caspase-8, whereas wild-type and caspase-11 knockout MEFs 
(C11 [   /   ]) remained sensitive to E2-25K/Hip-2 (  Fig. 3 B  ). 
This suggests caspase-12 is a critical mediator of E2-25K/
Hip-2 – mediated  cell  death. 
  E2-25K/Hip-2  –  mediated stabilization 
of caspase-12 protein via UPS 
  We next investigated how E2-25K/Hip-2 induces the accumula-
tion of caspase-12 protein. Although we found that both caspase-12 
mRNA and protein were regulated by E2-25K/Hip-2, we mainly 
  Oubrahim et al., 2005  ) and the promoter activity of caspase-12 in 
pGL3-0.8 was slightly increased by E2-25K/Hip-2 (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200711066/DC1). 
However, a quantitative comparison of our Western and RT-PCR 
analyses revealed that the reduction in caspase-12 protein was 
greater than that in caspase-12 mRNA in B103/E2-25K-AS 
cells (  Fig. 2 C  , left), suggesting that E2-25K/Hip-2 regulates 
caspase-12 at both the mRNA and protein levels. 
  Caspase-12 is a downstream mediator 
of E2-25K/Hip-2 in ER stress  –  induced 
cell death 
  Because caspase-12 is known to play an essential role in 
the apoptosis induced by ER stress, we examined the involve-
ment of E2-25K/Hip-2 in that process. Treating cells with 
thapsigargin or tunicamycin, which cause ER stress, induced 
cell death in   >  80% of control B103 cells but in a much smaller 
percentage of B103/E2-25K-AS cells (  Fig. 2 D  , left). Our Western 
analyses showed that thapsigargin and tunicamycin induced 
proteolytic activation of caspase-12 in control cells (  Fig. 2 D  , 
right), but levels of both procaspase-12 and activated cas-
pase-12 were reduced in B103/E2-25K-AS cells. In contrast, 
GADD153/CHOP, an ER stress marker (  Rao et al., 2002 ),  was 
induced equally in both cell lines. E2-25K/Hip-2 thus appears 
to contribute to ER stress  –  induced cell death and the activa-
  Figure 2.       E2-25K/Hip-2 is required for the ex-
pression and activation of caspase-12 during A    
toxicity.   (A) Knockdown (KD) of E2-25K/Hip-2 
expression reduces A    -induced expression and 
activation of caspase-12 protein. B103 cells 
were transfected with pcDNA3 (Mock) or anti-
sense (AS) E2-25K/Hip-2 cDNA (pAS-E2-25K/
Hip-2) and enriched by incubation with G418 
for 10 d (Mixed). The level of E2-25K/Hip-2 
expression was examined by Western analysis 
(left). Cells were incubated with 5   μ  M A      1-42   for 
48 h in serum-free culture medium, after which 
cell extracts were analyzed by Western blotting 
with anticaspase-2, -8, and -12 and anti  – 
    -tubulin antibodies (right). (B) Forced expression 
of E2-25K/Hip-2 induces proteolytic activation 
of caspase-12. B103 cells were transfected 
with pcDNA3 or pE2-25K/Hip-2 for 48 h 
and analyzed by Western blotting using the 
indicated antibodies. (C) E2-25K/Hip-2 regu-
lates the expression of both caspase-12 mRNA 
and protein. B103 cells stably transfected 
with  pcDNA3 (Mock) or pAS-E2-25K/Hip-2 
(#1 and #3) were isolated using single-cell clon-
ing methods. Expression of caspase-12 and 
E2-25K/Hip-2 was analyzed by Western blot-
ting or RT-PCR in the stable cell lines (left) and 
in the cells left untreated or exposed to 5   μ  M 
A     for 36 h (right). (D) E2-25K/Hip-2 KD cells 
are resistant to cell death induced by ER stress. 
Mock and stable E2-25K/Hip-2-AS cell lines 
(#1 and #3) were incubated with 0.1% vehicle 
(DMSO), 1   μ  M thapsigargin (Tg), or 2   μ  g/ml 
tunicamycin (Tuni.) for 24 h. Cell viability was 
then determined by trypan blue exclusion (  n   = 3). 
Bars depict means   ±   SD (left). Cell extracts 
were prepared and analyzed with Western 
blotting using the indicated antibodies (right). 
Asterisk indicates the processed form (p20 + 
p10) of caspase-12.     JCB • VOLUME 182 • NUMBER 4 • 2008  678
  We used in vitro ubiquitination assays to further charac-
terize E2-25K/Hip-2  –  dependent regulation of caspase-12 protein. 
Incubating ubiquitin with purifi   ed  GST – E2-25K/Hip-2  in  the 
presence of E1, ATP, and an ATP regeneration system led to the 
appearance of polyubiquitin (  Fig. 4 D  , left), which confi  rmed 
that the purifi  ed GST-E2-25K/Hip-2 protein is active and able 
to generate polyubiquitin. GST and GST-fused E2D (GST-E2D), 
another E2 ubiquitin-conjugating enzyme, served as negative con-
trols. Incubating B103 cell extract supplemented with ubiqui-
tin, E1, ATP, and an ATP regeneration system with either the 
purifi  ed GST  –  E2-25K/Hip-2 or MG132 led to the accumula-
tion of caspase-12 protein, but not caspase-3 (  Fig. 4 D  , middle 
and right) or I   B    (not depicted). The stability of caspase-12 
protein thus appears to refl  ect the ability of E2-25K/Hip-2 to 
generate polyubiquitin, which likely interferes with the degra-
dation of caspase-12 through the regulation of UPS. We then 
determined the subregion of caspase-12 required for MG132-
induced accumulation by using full length, prodomain-deleted 
mutant (    Pro), prodomain (Pro), or the large subunit (p20) of 
caspase-12. Compared with Pro,     Pro and p20 fragments are 
highly stabilized in the cells exposed to MG132 (10- and 7-fold 
each; Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200711066/DC1). 
  Modulation of ER stress responses and 
calpainlike activity by E2-25K/Hip-2 
  Caspase-12 can be activated by calpain during ER stress 
(  Nakagawa et al., 2000  ;   Nakagawa and Yuan, 2000  ), which 
prompted us to test whether E2-25K/Hip-2 is also involved in 
the regulation of calpain activity. Treatment with A     induced 
the accumulation of the ER stress marker GADD153/CHOP in 
control B103 cells, but not in B103/E2-25K-AS cells (  Fig. 5 A  ). 
In addition, a reporter assay using grp78 promoter luciferase 
showed that the overexpression of E2-25K/Hip-2, but not 
caspase-12, increased luciferase activity about threefold (  Fig. 5 B  ), 
indicating that E2-25K/Hip-2 is required for the induction of 
ER stress markers by A   . 
 Using  fl  uorogenic enzymatic assays, we consistently found 
that A     induced calpainlike activity in control cells (  Fig. 5 C  ), 
but not in B103/E2-25K-AS cells (#1 and #3). In addition, cal-
painlike activity was also induced by the ectopic expression 
of E2-25K/Hip-2, but not by the expression of E2-25K/Hip-2  – 
    tail mutant (  Fig. 5 D  ), which lacked the ability to inhibit pro-
teasome activity (  Song et al., 2003  ). Furthermore, E2-25K/Hip-2  – 
induced cell death was signifi  cantly attenuated by incubating 
the cells with calpeptin or z-LLY, calpainlike protease inhibitors 
(  Fig. 5 E  ), or by the overexpression of calpastatin, an endog-
enous inhibitor of calpain, with the reduction in the numbers 
of calpain activity-positive cells (  Fig. 5 F  ). E2-25K/Hip-2 thus 
appears to mediate the induction of calpainlike activity by A   , 
which may lead to activation of caspase-12. 
  As oxidative stress is another potent regulator of ER stress 
and a downstream mediator of A    , we also investigated the regu-
lation of E2-25K/Hip-2 and caspase-12 expression. We found 
that treating B103 cells with ascorbic acid, an antioxidant, but not 
Bapta-AM, a calcium chelator, reduced A   -induced  expression 
of E2-25K/Hip-2 and neurotoxicity (  Fig. 6 A  , top). Also, treatment 
focused on the stabilization of the protein because the regula-
tion at the protein level was more pronounced and the higher 
molecular mass forms of caspase-12 protein were found to 
accumulate in the brains of 9-mo-old APPswe/PS1dE9 dou-
ble transgenic mice (Fig. S2, available at http://www.jcb.org/
cgi/content/full/jcb.200711066/DC1). E2-25K/Hip-2 is an E2 
ubiquitin-conjugating enzyme capable of inhibiting protea-
some activity (  Song et al., 2003  ). We therefore hypothesized 
that caspase-12 may be regulated by protein degradation via 
proteasome. Western analysis showed that in contrast to caspase-3 
and -8, there was substantial dose-dependant accumulation of 
caspase-12 protein in B103 cells incubated with the protea-
some inhibitor MG132, but not with the lysosomal inhibitor 
NH  4  Cl (  Fig. 4 A   and Fig. S3). In contrast, the level of caspase-12 
mRNA was unchanged in cells exposed to MG132 (  Fig. 4 A  ). 
Immunoprecipitation analysis using antiubiquitin antibody 
confi  rmed that the accumulated forms of caspase-12 protein in 
cells exposed to MG132 were ubiquitinated (  Fig. 4 B  ). In ad-
dition, an exogenous caspase-12  –  GFP fusion protein was sta-
bilized in HEK293 cells incubated with MG132 (  Fig. 4 C  ). 
Also, the level of caspase-12  –  GFP fusion protein was increased 
by the coexpression with wild-type E2-25K/Hip-2, but not 
with E2-25K/Hip-2 Ser86 → Tyr (S86Y) or Cys92 → Ser (C92S) 
mutant (  Fig. 4 C  ), which lacked the capacity to inhibit protea-
some function (  Song et al., 2003  ). These results suggest that 
the degradation of caspase-12 protein is regulated by UPS and 
that E2-25K/Hip-2 stabilizes caspase-12 protein by inhibiting 
proteasome activity. 
  Figure 3.       Caspase-12 is a downstream molecule of E2-25K/Hip-2.   
(A) Effects of wild-type caspase-12 and an active site mutant (C298S) on 
E2-25K/Hip-2  –  induced cell death. B103 cells were transiently transfected 
with pE2-25K/Hip-2, pEGFP (Mock), pCaspase-12  –  GFP (C12), or pCas-
pase-12(C298S)  –  GFP (C298S), as indicated. Total amounts of plasmid 
DNA used were equalized by addition of pcDNA3. After 48 h, cell viabil-
ity was determined based on the morphology of GFP-positive cells under a 
ﬂ  uorescence microscope (* and **, P   <   0.001;   t   test). (B) Caspase-12 de-
ﬁ  ciency reduces E2-25K/Hip-2  –  mediated cell death. Wild-type (WT), C11 
(    /    ), and C12 (    /    ) MEFs were transfected with pEGFP and either 
pcDNA3 (Mock), pE2-25K/Hip-2 (E2-25K), or pCaspase-8 (Casp8). After 
48 h, cell viability was assessed as described in A. Bars depict means   ±   
SD (  n   = 3).     679 REGULATION OF CASPASE-12 BY E2-25K   •   S  ong et al. 
7-d-old E2-25K/Hip-2 knockout (   /   ) mice than wild-type 
(+/+) mice (  Fig. 7 A  ), and that the levels of caspase-12 mRNA 
were reduced in the brains of 9-mo-old E2-25K/Hip-2  –  defi  cient 
mice (  Fig. 7 B  ). Expression of both caspase-12 mRNA and pro-
tein thus appears to be regulated by E2-25K/Hip-2 in mice. 
  Bearing that in mind, we prepared in vitro cultures of pri-
mary cortical neurons from E2-25K/Hip-2 wild-type (+/+), hetero-
zygotic (+/    ), and homozygotic (   /   ) embryos at embryonic 
day 15 and examined their sensitivity to A     neurotoxicity. 
We found that E2-25K/Hip-2 (   /   ) neurons were completely 
resistant to A    , whereas E2-25K/Hip-2 (+/   )  neurons  showed 
partial resistance (  Fig. 7 C  ). In addition, immunocytochemical 
analysis revealed that caspase-12 and GRP78 proteins, which 
showed marked accumulation in E2-25K/Hip-2 (+/+) cortical 
neurons exposed to A    , were not induced by A     in E2-25K/
Hip-2 (   /   ) neurons (  Fig. 7 D  ), which confi  rms that E2-25K/
Hip-2 is indeed an essential regulator of caspase-12 and ER 
stress during A     neurotoxicity. 
  Discussion 
  The neurotoxicity of A     is a fundamental contributor to the 
pathogenesis and progression of AD (for review see   Barnham 
et al., 2006 ). To better understand A   neurotoxicity, we  examined the 
with H  2 O 2   induced the accumulation of E2-25K/Hip-2 (  Fig. 6 A  , 
bottom) and caspase-12 (  Fig. 6 C  ). In addition, H  2 O 2 -induced 
  accumulation and activation of caspase-12 were suppressed in 
B103/E2-25K/Hip-2-AS cells (  Fig. 6 C  ), and there was a con-
comitant inhibition of cell death ( Fig. 6 B ). Further, H  2 O 2 -induced 
accumulation of GADD153 observed in control B103 cells was 
also suppressed in E2-25K/Hip-2-AS cells (  Fig. 6 C  ). These re-
sults suggest that E2-25K/Hip-2 is required for cell death trig-
gered by H  2 O 2  -derived reactive oxygen species (ROS), which are 
also generated by A  , further supporting our proposal that E2-25K/
Hip-2 mediates ER stress responses. 
  E2-25K/Hip-2  –  deﬁ  cient cortical neurons 
are resistant to A     neurotoxicity 
 To evaluate the role of E2-25K/Hip-2 in the regulation of caspase-12 
and ER stress during A     neurotoxicity in vivo, we used a 
general protocol from BayGenomics to generate E2-25K/Hip-2  –
 defi  cient mice from embryonic stem cells in which a gene trap 
was inserted into the E2-25K/Hip-2 gene (Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200711066/DC1). 
The genotypes of the gene-trap insertion and depletion of E2-25K/
Hip-2 expression were confi  rmed using genomic DNA-PCR, 
RT-PCR, and Western analyses ( Fig. 7 A ). We found that the levels 
of caspase-12 protein were signifi  cantly lower in the brains of 
  Figure 4.       Stabilization of caspase-12 protein by E2-25K/Hip-2 via the UPS.   (A) Proteasome-dependent degradation of caspase-12. B103 cells were in-
cubated for 12 h with MG132, after which cell extracts were analyzed by Western blotting with anticaspase-3, -8, and -12 and anti  –      -tubulin antibodies, 
and by RT-PCR using oligonucleotides speciﬁ  c for caspase-12 and     -actin. (B) Detection of ubiquitinated caspase-12. B103 cells were incubated with 
5   μ  M MG132 for 12 h and cell extracts were prepared for Western blotting (Total) or subjected to immunoprecipitation (IP) using anti-HA (negative control) 
or antiubiquitin (Ub) antibody. The immunoprecipitates were analyzed by Western blotting with anticaspase-12 (top left) and anti  –  mouse IgG (bottom left) 
antibody; the latter showed the presence of equal amounts of IgG heavy chain (HC). (C) Stabilization of exogenous caspase-12  –  GFP (C12-GFP) fusion 
protein by ectopic expression of E2-25K/Hip-2, but not by its mutants. HEK293 cells were cotransfected for 24 h with pCaspase-12  –  GFP and either 
pcDNA3, pE2-25K/Hip-2 (W), or pE2-25K/Hip-2 mutant (S, S86Y; or C, C92S), and then cultured in the presence or absence of 0.1   μ  M MG132. Cell 
extracts were then analyzed by Western blotting with anti-GFP and anti  –  E2-25K/Hip-2 antibodies. (D) In vitro stabilization of caspase-12 protein by puri-
ﬁ  ed GST  –  E2-25K/Hip-2 protein. (Left) In vitro polyubiquitination by puriﬁ  ed GST  –  E2-25K/Hip-2 protein. GST-fused proteins (GST, GST  –  E2-25K/Hip-2, and 
GST-E2D) were puriﬁ  ed from   Escherichia coli   and preincubated with ubiquitin, E1, ATP, and an ATP regeneration system for 90 min at 37  °  C. The reaction 
products were analyzed by Western blotting with anti-GST antibody for the puriﬁ  ed proteins (top) and antiubiquitin antibody for ubiquitination (bottom; see 
Materials and methods). (middle) GST  –  E2-25K/Hip-2  –  induced in vitro accumulation of caspase-12. B103 cell extracts were prepared, supplemented with 
ubiquitin, E1, ATP, and an ATP regeneration system, and left untreated or incubated with either 5   μ  M MG132, GST, GST  –  E2-25K/Hip-2, or GST-E2D for 
2 h at 37  °  C. The reaction products were analyzed by Western blotting. (right) The caspase-12 signals on Western blots were quantiﬁ  ed by densitometry 
using the histogram function in Photoshop. Bars represent means   ±   SD (  n   = 3; *, P   <   0.01 vs. control). White lines indicate that intervening lanes have 
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mediates the induction of two ER stress markers, GADD153/
CHOP and GRP78, as well as the activation of calpain (  Fig. 8  ). 
In particular, experiments performed with E2-25K/Hip-2 knockout 
cortical neurons confi  rmed the essential role of E2-25K/Hip-2 
in A    -induced accumulation and activation of caspase-12 for 
neurotoxicity. Interestingly, the accumulation of caspase-12 
protein occurred via proteasome inhibition by E2-25K/Hip-2, 
which also ubiquitinates UBB 
+1  , causing the inhibition of 
proteasomeal activity in a dose-dependant way (for review see 
  Song and Jung, 2004  ;   van Tijn et al., 2007  ). Though the accu-
mulation of caspase-12 protein through proteasome inhibition 
is strongly plausible, it is still possible that E2-25K/Hip-2 may 
also accumulate caspase-12 protein by generating K63-linked 
ubiquitin chain (for review see   Lim et al., 2006  ). In contrast, the 
accumulation of caspase-12 mRNA was not observed in cells 
functional interactions of E2-25K/Hip-2, caspase-12, and ER 
stress, and we report here that E2-25K/Hip-2 regulates the ac-
cumulation and activation of caspase-12 in vitro and in vivo as 
a necessary step leading to A    -induced neuronal cell death. It is 
also clear that E2-25K/Hip-2 plays a central role in ER stress  –
  associated cell death triggered by A     and H  2 O 2 :  E2-25K/Hip-2 
  Figure 5.       Contribution of E2-25K/Hip-2 to A    -induced ER stress re-
sponses and calpainlike activity.   (A) Inhibition of A    -induced expression of 
GADD153 in E2-25K/Hip-2 KD cells. Mock and E2-25K/Hip-2-AS (#1) 
cells were incubated with A     for 48 h, after which cell extracts were exam-
ined by Western blotting with anti-GADD153 and anti  –      -tubulin antibodies. 
(B) Induction of GRP78 promoter activity by the ectopic expression of 
E2-25K/Hip-2. B103 cells were cotransfected with pGrp78-luciferase 
reporter and pcDNA3 (Mock), pE2-25K/Hip-2 (E2-25K), or pCaspase-12  – 
GFP (C12), and analyzed for luciferase activity as described in Mate-
rials and methods. (C and D) Induction of calpainlike protease activity by 
E2-25K/Hip-2. Calpainlike protease activity was measured using a ﬂ  uo-
rogenic substrate ([t-BOC-Leu-Me]2-R110; see Materials and methods) in 
Mock and E2-25K/Hip-2-AS cell lines (#1 and #3) after incubation with 
5   μ  M A     for 48 h (C) and in B103 cells transfected for 24 h with pE2-25K/
Hip-2 or pE2-25K/Hip-2  –      tail (D). (E) Suppression of E2-25K/Hip-2 neuro-
toxicity by calpain inhibitors. B103 cells were cotransfected with pEGFP 
and pE2-25K/Hip-2 for 48 h in the presence or absence of calpeptin or 
z-LLY, after which cell viability was determined based on the morphology of 
GFP-positive cells under a ﬂ  uorescence microscope (* and **, P   <   0.001). 
(F) Inhibition of E2-25K/Hip-2  –  induced cell death and calpain activa-
tion by calpastatin. B103 cells were transfected with pDsReD (Mock) or 
pDsRed-E2-25K/Hip-2 together with either pcDNA3 or pCalpastatin. 
After 48 h, cells were incubated with a ﬂ  uoregenic calpain substrate, 
7-amino-4-chloromethylcoumarin (t-BOC-Leu-Met; 1   μ  M), for 30 min. 
The cells showing shrinked morphology for dying cells (red ﬁ  lter; open bar) 
and/or calpain activity-positive ﬂ   uorescence (Hoescht ﬁ   lter; closed bar) 
were counted under a ﬂ  uorescence microscope as described in E (  n   = 3). 
Error bars represent SD.     
  Figure 6.       ROS induce caspase-12 via E2-25K/Hip-2 during A    neuro-
toxicity.   (A) The induction of E2-25K/Hip-2 by A     is mediated via ROS. 
B103 cells were incubated with 5   μ  M A      1-42   in the presence or absence 
of 300   μ  M ascorbic acid (Asc.) or 3   μ  M Bapta-AM (Bapta; top). B103 
cells were incubated for 48 h with the indicated concentrations of H  2  O  2   
in serum-free DME and analyzed by Western blotting with anti  –  E2-25K/
Hip-2 antibody (bottom). (B) E2-25K/Hip-2 KD cells are resistant to 
H  2  O  2   toxicity. B103 cells stably transfected with pcDNA3 (Mock) or 
pAS-E2-25K/Hip-2 (#1 and #3) were left untreated or incubated for 
48 h with 1   μ  M H  2  O  2   in serum-free DME, after which cell viability was 
assessed by trypan blue exclusion (  n   = 3). Bars depict means   ±   SD. 
(C) Induction of caspase-12 and GADD153 by H  2  O  2   is mediated by 
E2-25K/Hip-2. B103 cells stably transfected with pcDNA3 (Mock) or 
pAS-E2-25K/Hip-2 (#1) were incubated for 48 h with 1   μ  M H  2  O  2   in 
serum-free DME, after which cell extracts were prepared and analyzed 
by Western blotting with anticaspase-12, anti-GADD153, and anti  –   
  -tubulin antibodies.     681 REGULATION OF CASPASE-12 BY E2-25K   •   S  ong et al. 
proteolytic activation during A     neurotoxicity. In that sense, 
calpain inhibitors suppressed A     neurotoxicity.  Similar  accu-
mulation and activation of caspase-12 was observed in neuronal 
cells exposed to oxidative stress. However, calpain inhibitors 
still partially suppressed E2-25K/Hip-2  –  induced cell death, indi-
cating that an additional regulator (e.g., Jun N-terminal kinase) 
also functions as a downstream mediator of E2-25K/Hip-2 dur-
ing cell death (  Song et al., 2003  ). 
  We found that treating cultured cells with A     led  to 
E2-25K/Hip-2  –  dependent up-regulation of two ER stress markers, 
GADD153/CHOP and GRP78, as well as caspase-12, suggest-
ing E2-25K/Hip-2 is an upstream regulator of ER stress in A    
neurotoxicity (  Fig. 8  ). If so, the observed accumulation of 
caspase-12 in the brains of APP transgenic mice might be induced 
by the increased expression of E2-25K/Hip-2, which would be 
expected to further increase neuronal susceptibility to cell death 
or stress. We believe that E2-25K/Hip-2 may induce ER stress 
via generating unanchored polyubiquitin, which is able to in-
hibit proteasome activity in vitro like polyubiquitinated UBB 
+1  
(  Song et al., 2003  ;   van Tijn et al., 2007  ; for review see   Song and 
Jung, 2004  ). That said, it is noteworthy that the contributions of 
E2-25K/Hip-2 to the induction of GADD153/CHOP in cells ex-
posed to various ER stress signals differ. For instance, E2-25K/
Hip-2 is required for the induction of GADD153/CHOP by A    
and ROS, but not by tunicamycin or thapsigargin, implying that 
E2-25K/Hip-2 might be more specifi  c to ER stress response 
caused by A     than by tunicamycin or thapsigargin. Thus, a pos-
sible model is that E2-25K/Hip-2 may be situated upstream of 
intracellular calcium destabilization or at the accumulation of 
exposed to MG132, though the promoter activity of caspase-12 
(pGL3-08) was weakly induced by coexpression of E2-25K/Hip-2. 
Thus, the regulation of caspase-12 mRNA by E2-25K/Hip-2 is 
separated from its proteasome inhibitory activity. 
  Although caspase-12 is a proximal caspase and is an im-
portant mediator of apoptosis triggered by ER stress, we believe 
its accumulation may not, itself, be suffi  cient to induce cell 
death. When we overexpressed caspase-12 in various cell types, 
including fi  broblasts and neuronal cells, it was much less effec-
tive in inducing cell death than other proximal caspases, such 
as caspase-8, -9, and -10 (unpublished data). To be effective, ap-
parently, caspase-12 needs to interact with one or more activators. 
In our study, E2-25K/Hip-2 was able to induce both calpain-
like activity and effi  cient proteolytic processing of caspase-12. 
One possible explanation is that the inhibition of proteasome 
activity by E2-25K/Hip-2 leads to an accumulation of misfolded 
proteins within cells, which in turn induces ER stress, includ-
ing the activation of calpain. Consistent with that idea, it has 
been shown that the inhibition of proteasome activity by aggre-
gation-prone proteins or proteasome inhibitors does indeed 
induce ER stress (  Kouroku et al., 2002  ;   Nishitoh et al., 2002  ; 
  Nawrocki et al., 2005  ). Still, the details of the molecular path-
way downstream of E2-25K/Hip-2 leading to induction of cal-
painlike activity remain unclear. 
  Along with those of an earlier paper showing that calpain 
directly activates caspase-12 (  Nakagawa et al., 2000  ), our pre-
sent fi  ndings suggest that calpainlike activity is required for 
proteolytic activation of caspase-12. This means that E2-25K/
Hip-2 regulates both the accumulation of caspase-12 and its 
  Figure 7.       Down-regulation of caspase-12 and resistance of E2-25K/Hip-2  –  deﬁ  cient primary cortical neurons to A     toxicity  . (A) Generation of E2-25K/
Hip-2  –  deﬁ  cient mice. E2-25K/Hip-2  –  deﬁ  cient mice were generated from XK109 embryonic stem cells manipulated using the gene-trap method. Genomic 
DNA and mRNA were puriﬁ  ed from the tails of E2-25K/Hip-2  –  trapped mice and analyzed using genomic DNA-PCR and RT-PCR (Tail). Brain extracts 
were prepared from postnatal E2-25K/Hip-2 wild-type (+/+), heterozygotic (+/    ), and homozygotic (    /    ) mice and analyzed by Western blotting with 
anti  –  E2-25K/Hip-2 and anticaspase-12 antibodies (Brain). (B) Reduction of caspase-12 mRNA in the brains of 9-mo-old E2-25K/Hip-2  –  deﬁ  cient mice. 
Total RNA was analyzed with RT-PCR using synthetic oligonucleotides for E2-25K/Hip-2 and caspase-12, as described in Materials and methods. 
(C) Resistance of E2-25K/Hip-2  –  deﬁ  cient cortical neurons to A     toxicity. Primary cortical neurons from E2-25K/Hip-2 wild-type (+/+), heterozygotic (+/    ), 
and homozygotic (    /    ) embryos at embryonic day 15 were cultured for 3 d and incubated with A     for 2 d. Cell morphology was observed (top) and 
cell viability was examined after staining with Calcein-AM (  n   = 3; bottom). Bars depict means   ±   SD. (D) Lack of A    -induced increase of caspase-12 
and GRP78 in E2-25K/Hip-2  –  deﬁ  cient neurons. Primary cortical neurons cultured from E2-25K/Hip-2 wild-type (+/+) and homozygotic (    /    ) embryos 
at embryonic day 15 were left untreated or incubated for 48 h with A    , immunostained using anti-GRP78 (left) and anticaspase-12 (right) antibodies, 
and examined under a confocal microscope (see Materials and methods). Nuclei were stained with hoechst dye; arrowheads indicate the induction of 
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  Materials and methods 
  Proteasome and calpain inhibitor 
  Proteasome inhibitor MG132 (Sigma-Aldrich), calpain inhibitors z-LLY 
(EMD), and calpeptin (EMD) were purchased. 
  Plasmid construction and RT-PCR 
  pE2-25K/Hip-2 and its mutants (    tail, deletion of tail region; S86Y, Ser  →
  Tyr; C92S substitution, Cys  →  Ser) were described previously (  Song et al., 
2003  ). pCaspase-12  –  GFP and its active site mutant (C298S) have also 
been described previously (  Nakagawa et al., 2000  ). E2-25K/Hip-2 cDNA 
was subcloned into pcDNA3 in an antisense orientation (pAS-E2-25K/Hip-2). 
To coexpress with calpastatin, E2-25K/Hip-2 was cloned into the EcoRI 
and BamHI sites of pDsReD-C2 (Clontech Laboratories, Inc.) using synthetic 
oligonucleotides mRed-Hip-2-5     (5    -GCGAATTCTATGGCCAACATCGCG-
GTG-3    ) and mRed-Hip-2-3     (5    -GCGGATCCTCAGTTACTCAGAAGCAA-3    ). 
Human calpastatin cDNA cloned in pCMV-SPORT6 vector was purchased 
from Korea Research Institute of Bioscience and Biotechnology. 
  Total RNA was puriﬁ  ed and reverse transcribed as described previ-
ously (  Song et al., 2003  ). Levels of E2-25K/Hip-2, caspase-12,     -actin, 
and glyceraldehyde-3-phosphate dehydrogenase mRNA were analyzed 
using PCR with gene-speciﬁ  c synthetic oligonucleotides. 
  Cell culture, DNA transfection, and assessment of cell death 
  Wild-type MEFs, caspase-11 (    /    ) MEFs, and caspase-12 (    /    ) MEFs 
were provided by J. Yuan (Harvard Medical School, Boston, MA). MEFs, 
B103 cells (rat neuroblastoma), and HEK293 cells (human embryonic kid-
ney cells) were cultured in DME supplemented with 10% (vol/vol) fetal bo-
vine serum. Cells were transfected using Lipofectamine Reagent (Invitrogen) 
according to the manufacturer  ’  s protocol, after which their viability was as-
sessed based on the morphology of GFP-positive cells viewed under a ﬂ  uo-
rescence microscope (DMRBE; Leica), trypan blue exclusion assays, and 
live/dead cell assays (Invitrogen). 
  Preparation and treatment with A      1-42   peptide 
  Commercially available A      1-42   was purchased from Sigma-Aldrich and 
dissolved to a concentration of 500   μ  M in phosphate-buffered saline. 
The A      1-42   stock solution was incubated for 1 wk at 4  °  C and divided into 
small aliquots for storage at     70  °  C. Cells were incubated with A      1-42   or 
other cell death  –  inducing drugs including tunicamycin (Sigma-Aldrich) and 
thapsigargin (Sigma-Aldrich) in serum-free DME. 
  Luciferase and     -galactosidase (    -gal) assays 
  B103 cells were cotransfected with Grp78-luciferase reporter plasmid, cyto-
megalovirus     -gal, and effecter plasmids. After 32 h, the cells were har-
vested and the luciferase activities in the cell extracts were determined 
using a Luciferase assay system (Promega). To measure     -gal activity, cell 
extracts were mixed with equal amounts of     -gal buffer (2  ×  ) containing 
200 mM sodium phosphate, pH 7.3, 2 mM MgCl  2  , 100 mM     -mercapto-
ethanol, and 1.33 mg/ml   O  -Nitrophenyl-    -D-galactopyranoside, and incu-
bated for 1 h at 37  °  C. The absorbance at 420 nm was then measured 
using a microplate reader (Bio-Rad Laboratories). 
  Enrichment of antisense E2-25K/Hip-2 cDNA-transfected cells 
  B103 cells were transfected with pAS-E2-25K/Hip-2 or pcDNA3 for 24 h 
and incubated with 800   μ  g/ml G418 sulfate (Invitrogen) for 10 d to gener-
ate a stable mixed cell population. Single-cell clones (E2-25K-AS #1 and 
#3) were isolated using standard cell cloning methods and examined for 
expression of E2-25K/Hip-2 using Western analysis. 
  Transgenic mice 
  Tg2576 transgenic mice (13  –  22 mo of age) were used in our study. Each 
expressed human APP 695 containing the double K670N/M671L mutation 
(huAPP695.K67ON/M671L) found in a large Swedish family with early 
  onset AD (  Hsiao et al., 1996  ). Double transgenic mice expressing APPswe 
and PS1dE9 exon 9  –  deleted PS1dE9 (The Jackson Laboratory) were pur-
chased and bred to generate transgenic mice and wild-type littermates. 
  Antibody generation, Western blotting, and immunocytochemistry 
  Generation of anti  –  E2-25K/Hip-2 and anticaspase-8 antibodies was de-
scribed previously (  Kim et al., 2002  ;   Song et al., 2003  ). Anti  –      -tubulin (Sigma-
Aldrich), anticaspase-2 (Santa Cruz Biotechnology, Inc.), anticaspase-3 
(Biomeda), anticaspase-12 (Santa Cruz Biotechnology, Inc.), and anti-GFP 
(Santa Cruz Biotechnology, Inc.) antibodies were purchased. Cells were 
lyzed in sampling buffer (10% glycerol, 2% SDS, 62.5 mM Tris-HCl, and 
unfolded proteins found in the case of A     neurotoxicity (  Fig. 8  ; 
  Nakagawa et al., 2000  ;   Ferreiro et al., 2006  ). 
  It has been proposed that oxidative stress contributes to 
the progression of pathological processes in neurons, including 
AD (  Manton et al., 2004  ; for review see   Huber et al., 2006  ). 
We found that E2-25K/Hip-2 accumulated in B103 cells exposed 
to ROS and that antioxidants, which suppress A     neurotoxicity 
(  Hensley et al., 1994  ;   Bruce et al., 1996  ), inhibited the accumu-
lation of E2-25K/Hip-2. The regulation of E2-25K/Hip-2 ex-
pression may thus be involved in mediating oxidative damage 
underlying neuronal pathology. Recently, E2-25K/Hip-2 was 
proposed to be involved in the aggregation of polyglutamine-
expanded Huntingtin with proteasome inhibitory activity (  de Pril 
et al., 2007  ). Thus, it would be interesting to know whether 
E2-25K/Hip-2 is associated with the pathogenesis of other neuro-
degenerative ailments, including Huntington  ’  s and Parkinson  ’  s 
disease, because malfunction of the UPS, its diminished activ-
ity, and generation of ROS are common phenomena in neuro-
degenerative diseases (for review see   Song and Jung, 2004  ; 
 Halliwell,  2006 ). 
 A  -induced,  E2-25K/Hip-2 – dependent  regulation  of 
caspase-12 and ER stress was confi  rmed in E2-25K/Hip-2  – 
defi  cient neurons. Despite the important role of E2-25K/Hip-2 in 
the regulation of ER stress, E2-25K/Hip-2  –  defi  cient (   /  )  mice 
were well bred and healthy until the age of 9 mo. The absence of 
any detectable defects during the development of these mice sug-
gests that the function of E2-25K/Hip-2 might be compensated 
for during that period by other E2s, like Mdm2, which interacts 
with several E2s to ubiquitinate tumor suppressor p53 (  Saville 
et al., 2004  ). Alternatively, E2-25K/Hip-2 may be mainly associ-
ated with neuronal pathogenesis. Although a human homologue 
of caspase-12 is in debate, our identifi  cation of E2-25K/Hip-2 as an 
upstream regulator of ER stress suggests that E2-25K/Hip-2 could 
serve as a plausible therapeutic target for the treatment of AD. 
  Figure 8.       Schematic diagram showing the regulation of caspase-12 and 
ER stress by E2-25K/Hip-2 during A     neurotoxicity.   The gray box depicts 
the inhibitory effect of E2-25K/Hip-2 on the proteasome activity via the 
accumulation of polyubiquitin (Poly Ub) and ubiquitinated UBB 
+1   (Ubs-
UBB 
+1  ;   Song et al., 2003  ). Unanchored polyubiquitin is able to interact 
with proteasome in vitro (  Piotrowski et al., 1997)  , which is similar to the 
proteasome inhibition by Ubs-UBB 
+1   (  van Tijn et al., 2007  ). A     stimulates 
the expression of E2-25K/Hip-2 via oxidative stresses (ROS) and E2-25K/
Hip-2 stimulates up-regulation of caspase-12 mRNA and protein. E2-25K/
Hip-2 also mediates the induction of GRP78 and calpainlike activity, which 
is believed to activate caspase-12 during A     neurotoxicity.     683 REGULATION OF CASPASE-12 BY E2-25K   •   S  ong et al. 
Hip-2 (E2-25K/Hip-2-5     and E2-25K/Hip-2-3    ) and     -gal. The absence of 
E2-25K/Hip-2 expression in homozygous mice was conﬁ  rmed by Western 
analysis of the proteins extracted from the brains of 5-d-old mice. 
  Primary culture of cortical neurons 
  E2-25K/Hip-2 heterozygous mice were interbred to generate homo-
zygous, heterozygous, and wild-type embryos. Cortical tissues from em-
bryonic day 14.5 embryonic brains were dissociated by incubation 
with 0.01% trypsin-EDTA (Invitrogen) and plated on culture dishes coated 
with poly-  L  -lysine (0.01% in 100 mM borate buffer, pH 8.5). Details of 
the procedures were described previously (  Song et al., 2003  ). Cortical 
neurons from each embryo were plated separately and their genotypes 
were examined by Western blotting and genomic PCR. Neurons were 
  cultured for 3 d before treatment with A     in the serum-free minimum es-
sential medium. 
  Online supplemental material 
  In Fig. S1 the reporter assay showed that the promoter activity of caspase-12 
in pGL3-0.8 was slightly increased by E2-25K/Hip-2. Western analysis 
showed that the higher molecular mass forms of caspase-12 protein ac-
cumulated in the brains of 9-mo-old APPswe/PS1dE9 double transgenic 
mice (Fig. S2), and that caspase-12 protein accumulated in B103 cells 
incubated with the proteasome inhibitor MG132 (Fig. S3). Further, in 
Fig. S4 DPro and p20 fragments of caspase-12 were highly stabilized 
in the cells exposed to MG132 (10- and sevenfold each). Fig. S5 shows 
the genomic locus of the gene-trap insertion in E2-25K/Hip-2  –  deﬁ  cient 
mice. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200711066/DC1. 
Supplemental materials and methods
Lysosomal inhibitor. Lysosome inhibitor ammonium chloride (NH  4  Cl; Sigma-
Aldrich) was purchased.
Plasmid construction. Serial deletions of caspase-12 were generated 
by PCR using synthetic oligonucleotides (C12full 5    KpnI [5    -GGTACCCG-
CATGGCGGCCAGGAGGACACAT-3    ], C12full 3    KpnI [5    -GGTACCCG-
CATTCCCGGGAAAAAGGTAGAA-3    ], C12    pro 5    HindIII [5    -AAGCTTC-
GCATGTGTCCACGTGATCAGT-3    ], C12    pro 3    HindIII [5    -AAGCTTCG-
CATTCCCGGGAAAAAGGTAGAA-3    ], C12pro 5    HindIII [5    -AAGCTTC-
GCATGGCGGCCAGGAGGACACAT-3    ], C12pro 3    HindIII [5    -AAGCTT-
CAGTGTATCTTGGACTTCTGA-3    ], and C12p20 3    KpnI [5    -GGTACCC-
GCATCAGCAGTGGCTATCCC-3    ]), after which the PCR products were 
subcloned into pcDNA3-HA. Caspase-12 promoter constructs (pGL3-3.0 
and pGL3-0.8) were previously described (  Oubrahim et al., 2005  ).
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2%     -mercaptoethanol, pH 6.8), after which aliquots of lysate containing 
equal amounts of protein were subjected to SDS-PAGE and Western analy-
sis as described previously (  Kim et al., 2002  ). Primary neurons were ana-
lyzed with immunocytochemistry using anti-GRP78 (dilution 1:200; Santa 
Cruz Biotechnology, Inc.) and anticaspase-12 (dilution 1:50) primary anti-
bodies and Alexa Fluor 488  –   or 555  –  conjugated secondary antibodies 
(1:1,000; Invitrogen) as described previously (  Song et al., 2003  ). 
  Histology and immunohistochemistry 
  12-  μ  m-thick frozen brain sections, which were taken from the human Swed-
ish mutant amyloid precursor protein (huAPP695.K670N/M671L) trans-
genic Tg2576 and their littermate mice at the age of 21 mo, were ﬁ  xed 
with 4% PFA and blocked with 3% normal serum and 0.3% Triton X-100 in 
phosphate-buffered saline, pH 7.4. After coincubation with rabbit anti  – 
E2-25K/Hip-2 antibody (dilution, 1:200) and rat anticaspase-12 antibody 
(1:25), the sections were reacted with Alexa Fluor 488  –   or 555  –  conjugated 
secondary antibody (1:1,000). For the double ﬂ  uorescent immunostaining 
with rabbit anti  –  E2-25K/Hip-2 antibody and rabbit anticaspase-2 anti-
body (1:100), we treated the primary antibodies with Zenon Alexa Fluor 
rabbit IgG labeling kit (Invitrogen) before the reaction with the tissue sec-
tions. All stained samples were mounted using a mounting medium for 
ﬂ  uorescence (VECTASHIELD; Vector Laboratories). 
  Microscopy 
  Immunohistochemical studies were photographed under a ﬂ  uorescence 
microscope (Eclipse 80i with Plan Apo VC 100  ×  /1.40 Oil WD 0.13. lens; 
Nikon) using the manufacturer  ’  s acquisition system (DS-Fi1/DS-U2 digital 
camera and NIS-Elements F 2.20 program). Fluorescence (IX71S1F-3 with 
two objective lenses [LCPlanFl, 40  ×  /0.60 Ph2 and 20  ×  /0.45 Ph1]; Olym-
pus) and confocal microscopes (UltraVIEW ERS FRET-EH with an oil immer-
sion objective lens [DIC-H, 100  ×  /1.40]; PerkinElmer] were used for analysis 
of the immunostained samples. Images were captured using each manufac-
turer  ’  s acquisition system (DP20 digital camera and DP ver.3.1.1.208 man-
ager program [Olympus]; UltraVIEW LCI [PerkinElmer]). All stained samples 
were examined at room temperature and Photoshop (Adobe) was used to 
make combinatory ﬁ  gures (color contrast, medium). 
  In vitro degradation assay 
  Various GST-fused proteins cloned into pGEX4T-1 (GST  –  E2-25K/Hip-2 
[provided by S. Kang, Korea University, Seoul, Korea] and GST-E2D) were 
expressed in DH5     cells and puriﬁ  ed using glutathione  –  Sepharose 4B (GE 
Healthcare). For in vitro degradation assays, B103 cells (5   ×   10 
7  ) were 
harvested and lyzed in tris-based buffer (10 mM Tris-HCl, 0.05% NP-40, 
150 mM NaCl, 3 mM MgCl  2  , 0.5 mM PMSF, 1 mM EDTA, 1 mM ATP, and 
1 mM DTT). Cell extract was incubated for 2 h at 37  °  C in the presence or 
absence of GST-fused proteins preincubated with puriﬁ  ed ubiquitin (Sigma-
Aldrich), ubiquitin-activating enzyme E1 (Macrogen), and 10 mM ATP. Pro-
tein degradation was then analyzed by Western blotting. 
  Measurement of calpainlike protease activity 
  The rhodamine 110-based substrate, (t-BOC-Leu-Met)2-R110, and chloro-
methylcoumarin-based substrate, CMAC-(t-BOC-Leu-Met; Invitrogen), were 
used as a calpain substrate to assess calpainlike protease activity in intact 
cells. When (t-BOC-Leu-Met)2-R110 was used, B103 cells were sedimented 
and resuspended in Hepes-buffered saline (5 mM Hepes and 0.15 NaCl, 
pH 7.35) containing 2 mM EDTA (Hepes-buffered saline  –  EDTA) to a 
density of     0.5    10 
7   cells/ml. Cells diluted by 100  ×   were incubated 
with 10   μ  M of substrate for 20 min at 37  °  C. After washing twice with 
HBSS-EDTA, the ﬂ  uorescence emitted by the cells was measured using a 
ﬂ   uorescence microplate reader (FL-600; BioTek Instruments, Inc.). In the 
case of CMAC-(t-BOC-Leu-Met), B103 cells were incubated with 1   μ  M of 
substrate for 30 min and examined under a ﬂ  uorescence microscope using 
a Hoescht ﬁ  lter. 
  Generation of E2-25K/Hip-2  –  deﬁ  cient mice 
  E2-25K/Hip-2 gene-trapped embryonic stem cells (XK109) were provided 
by BayGenomics of the International Gene Trap Consortium. Mice hetero-
zygotic for E2-25K/Hip-2 were generated by following the protocol pro-
vided by BayGenomics. Insertion of the gene-trap vector was conﬁ  rmed by 
Southern blotting using NEBlot Phototope (New England Biolabs, Inc.) with 
a     -gal probe recommended by BayGenomics. Genotypes were analyzed 
using genomic PCR with synthetic oligonucleotides for     -gal (    -gal-5    , 
5    -TTATCGATGAGCGTGGTGGTTATGC-3    ;     -gal-3    , 5    -GCGCGTACATC-
GGGCAAATAATATC-3    ) and     -actin. The expression of E2-25K/Hip-2 was 
examined using RT-PCR with synthetic oligonucleotides derived from E2-25K/JCB • VOLUME 182 • NUMBER 4 • 2008  684
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